×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
返回 Agenda
Session 24: FDA Enforcement Actions: Form FDA 483 and Warning Letters
Session Chair(s)
Albert S. Yehaskel, MBA
President and CEO
Refuah Global Pharmaceutical Development, Inc., United States
- Types of Enforcement Actions
- FDA Inspections and Inspection Documents
- Form FDA 482, 483, and 484
- Warning Letters
- Addressing a Warning Letter
- cGMP Deviations